Internal Medicine, Medical Oncology · Dallas, TX
NPI
1144267766
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2201 Inwood Rd
Dallas, TX, 75235
Phone (214) 645-4673
Groups this clinician bills Medicare through
Medicare paid, 2024
$74K
692 services
Medicare patients, 2024
330
Average age 74
Drug cost, 2024
$16.1M
2,703 prescriptions
Company payments, 2025
$17K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Larry D Anderson Jr. was code 99215 (office e&m - established), 279 times for 185 patients. In total Larry D Anderson Jr. billed 692 services in 11 codes, and Medicare paid $74K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-05-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 279 | 185 | $126.25 | $35K |
| 99214 Office E&M - Established | Office | 137 | 118 | $76.85 | $11K |
| 99215 Office E&M - Established | Facility | 112 | 79 | $110.36 | $12K |
| 99233 Hospital E&M - Subsequent | Facility | 89 | 31 | $92.04 | $8,191 |
| 99443 Telephone Services | Office | 23 | 20 | $84.55 | $1,945 |
| 99223 Hospital E&M - Initial | Facility | 17 | 17 | $128.69 | $2,188 |
| 99239 Hospital Discharge Management | Facility | 13 | 11 | $88.73 | $1,154 |
By year: 2022 $128K for 1,299 services; 2023 $68K for 785 services; 2024 $74K for 692 services.
Medicare prescription drug claims, 2024
In 2024, the drug Larry D Anderson Jr. prescribed most often to Medicare patients was Lenalidomide, with 360 prescriptions and refills. In total Larry D Anderson Jr. wrote 2,703 Medicare prescriptions that cost $16.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lenalidomide Generic | 360 | 360 | 49 | $4.4M |
| Acyclovir Generic | 244 | 402 | 69 | $3,352 |
| Revlimid Lenalidomide | 229 | 229 | 44 | $4.1M |
| Pomalyst Pomalidomide | 228 | 228 | 33 | $4.9M |
| Dexamethasone Generic | 188 | 272 | 57 | $2,261 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 148 | 149 | 28 | $5,234 |
| Gabapentin Generic | 79 | 96 | 14 | $1,362 |
| Eliquis Apixaban | 75 | 91 | 15 | $52K |
| Brukinsa Zanubrutinib | 66 | 69 | Under 11 | $823K |
| Ninlaro Ixazomib Citrate | 61 | 61 | Under 11 | $771K |
| Potassium Chloride Generic | 58 | 125 | 24 | $1,529 |
| Valacyclovir Valacyclovir Hcl | 50 | 79 | 16 | $1,655 |
| Zolpidem Tartrate Generic | 50 | 54 | 11 | $214 |
| Ondansetron Hcl Generic | 47 | 47 | 31 | $277 |
| Fentanyl Generic | 35 | 35 | Under 11 | $4,069 |
Brand drugs: - claims; generic drugs: 1,926 claims; opioid claims: 238.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Larry D Anderson Jr. $17K ($17K in general payments such as food, travel and fees) from 18 companies. The largest payer was Janssen Biotech, Inc. with $6,822.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 11 | $6,822 |
| Kite Pharma, Inc. GILD | 2 | $4,420 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $2,993 |
| Pfizer Inc. PFE | 1 | $1,890 |
| Karyopharm Therapeutics Inc. KPTI | 2 | $324 |
| Genzyme Corporation SNY | 2 | $268 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $195 |
| Adaptive Biotechnologies Corporation ADPT | 1 | $172 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $129 |
| AstraZeneca UK Limited AZN | 1 | $96.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.